Manfred Peter Wirth
Impact in
- Urology top 0.2%
- Urinary Bladder and Prostate Research
- Pulmonary and Respiratory Medicine top 0.2%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
Papers in
-
- Prostate Cancer Diagnosis and Treatment 123
- Prostate Cancer Treatment and Research 117
- Renal cell carcinoma treatment 48
- Surgery 121
- Bladder and Urothelial Cancer Treatments 76
- Co-authors
- Oliver Walther Hakenberg (62 shared papers)Susanne Fuessel (63 shared papers)Michael Froehner (87 shared papers)Michael Froehner (58 shared papers)Axel Meye (39 shared papers)Andreas Manseck (42 shared papers)Rainer Koch (66 shared papers)Oliver W. Hakenberg (32 shared papers)
- Journals
- European Urology (52 papers)Urology (33 papers)The Journal of Urology (31 papers)British Journal of Urology (21 papers)World Journal of Urology (14 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Manfred Peter Wirth
442 papers receiving 11.6k citations
Manfred Peter Wirth's Hit Papers
Peers
Comparison fields: 5 of 150
- Urology 998
- Pulmonary and Respiratory Medicine 5.1k
- Surgery 3.0k
- Cancer Research 971
- Oncology 1.6k
Countries citing papers authored by Manfred Peter Wirth
This map shows the geographic impact of Manfred Peter Wirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Peter Wirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Peter Wirth more than expected).
Fields of papers citing papers by Manfred Peter Wirth
This network shows the impact of papers produced by Manfred Peter Wirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Peter Wirth. The network helps show where Manfred Peter Wirth may publish in the future.
Co-authors
The 25 scholars most cited alongside Manfred Peter Wirth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 467 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95 Hit paper breakdown → | 2009 | 657 |
| 2 | Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2021 | 488 |
| 3 | Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial Hit paper breakdown → | 2014 | 313 |
| 4 | 2011 | 267 | |
| 5 | 2006 | 229 | |
| 6 | 2010 | 223 | |
| 7 | Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2022 | 210 |
| 8 | 2005 | 207 | |
| 9 | 2015 | 203 | |
| 10 | 2010 | 195 | |
| 11 | 2002 | 179 | |
| 12 | 2004 | 156 | |
| 13 | 2017 | 150 | |
| 14 | 2014 | 144 | |
| 15 | 2000 | 142 | |
| 16 | 2014 | 137 | |
| 17 | Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. | 2003 | 117 |
| 18 | 2006 | 106 | |
| 19 | 2006 | 106 | |
| 20 | 2015 | 105 |
About Manfred Peter Wirth
Manfred Peter Wirth is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Urology, Oncology and Cancer Research, having authored 467 papers that have together received 11.9k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (123 papers), Prostate Cancer Treatment and Research (117 papers), Bladder and Urothelial Cancer Treatments (76 papers), Renal cell carcinoma treatment (48 papers), Urinary Bladder and Prostate Research (22 papers), Urological Disorders and Treatments (19 papers), Urologic and reproductive health conditions (17 papers) and Cancer, Lipids, and Metabolism (15 papers). The work is most often cited by research in Urology (998 citations), Pulmonary and Respiratory Medicine (5.1k citations), Surgery (3.0k citations), Cancer Research (971 citations) and Oncology (1.6k citations). Manfred Peter Wirth has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Oliver Walther Hakenberg, Susanne Fuessel, Michael Froehner, Michael Froehner, Axel Meye, Andreas Manseck, Rainer Koch, Oliver W. Hakenberg, Stefan Zastrow and Vladimír Novotný. Their work appears in journals such as European Urology, Urology, The Journal of Urology, British Journal of Urology and World Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.